A
Anbio Biotechnology
NASDAQ:NNNN
Anbio Biotechnology
NASDAQ:NNNN
Price:
25.76
USD
-6.5%
Market Cap:
$3.7B
Balance Sheet
Balance Sheet Decomposition
Anbio Biotechnology
Anbio Biotechnology
Balance Sheet Decomposition is not available for
Anbio Biotechnology
Anbio Biotechnology
Balance Sheet
Anbio Biotechnology
Anbio Biotechnology
Currency:
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
4
|
7
|
10
|
12
|
|
| Cash Equivalents |
4
|
7
|
10
|
12
|
|
| Short-Term Investments |
0
|
2
|
0
|
0
|
|
| Total Receivables |
1
|
0
|
2
|
1
|
|
| Accounts Receivables |
1
|
0
|
2
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
5
|
4
|
6
|
|
| Total Current Assets |
5
|
14
|
16
|
19
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
|
| Total Assets |
5
N/A
|
14
+184%
|
16
+13%
|
19
+20%
|
|
| Liabilities | |||||
| Accounts Payable |
2
|
1
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
1
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
1
-41%
|
1
-30%
|
2
+74%
|
|
| Equity | |||||
| Common Stock |
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
13
|
15
|
17
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
13
+395%
|
15
+18%
|
17
+16%
|
|
| Total Liabilities & Equity |
5
N/A
|
14
+184%
|
16
+13%
|
19
+20%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
142
|
144
|
144
|
142
|
|
Switch to:
Switch to:
See Also
Discover More
